BL
VRTX icon

BFSG LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

BFSG LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.3K Hold
61
– – ﹤0.01% 476
2026
Q1 		$27.2K Buy
61
+7
+13% +$3.26K ﹤0.01% 467
2025
Q4 		$24.5K Hold
54
– – ﹤0.01% 466
2025
Q3 		$21.1K Hold
54
– – ﹤0.01% 470
2025
Q2 		$24K Hold
54
– – ﹤0.01% 443
2025
Q1 		$26.2K Hold
54
– – ﹤0.01% 418
2024
Q4 		$21.7K Hold
54
– – ﹤0.01% 442
2024
Q3 		$25.1K Hold
54
– – ﹤0.01% 427
2024
Q2 		$25.3K Hold
54
– – ﹤0.01% 412
2024
Q1 		$22.6K Buy
+54
New +$22.8K ﹤0.01% 438

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

BFSG LLC's VRTX Position: Q2 2026 in Review

BFSG LLC held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 61 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

BFSG LLC first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • BFSG LLC held 61 shares of Vertex Pharmaceuticals worth $30.3K as of Q2 2026.
  • BFSG LLC left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #476 holding.
  • BFSG LLC first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.